AFNAS
PTCT icon

American Financial Network Advisory Services’s PTC Therapeutics PTCT Stock Holding History

American Financial Network Advisory Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-46
Closed -$1K – 738
2017
Q3 		$1K Buy
+46
New +$901 ﹤0.01% 744

Other funds holding PTCT

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

American Financial Network Advisory Services's PTCT Position: Q4 2017 in Review

American Financial Network Advisory Services sold out of PTC Therapeutics (PTCT) in Q4 2017, closing a stake of 46 shares — an estimated $1K sold.

American Financial Network Advisory Services first reported a position in PTCT in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 125 funds tracked by Wall St. Rank hold PTCT as of Q4 2017.

  • American Financial Network Advisory Services reported no remaining PTC Therapeutics position as of Q4 2017 after selling out during the quarter.
  • American Financial Network Advisory Services sold 46 PTC Therapeutics shares in Q4 2017, an estimated $1K.
  • American Financial Network Advisory Services first reported a position in PTC Therapeutics in Q3 2017 and held it in 1 quarter.
  • American Financial Network Advisory Services's PTC Therapeutics position peaked at $1K in Q3 2017.
  • 125 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2017.

Based on American Financial Network Advisory Services's 13F filing for Q4 2017, filed 2 Jan 2018.